Calcimedica is a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC) channels for the treatment of inflammatory and autoimmune disorders and organ transplant rejection.
12
Funding Rounds
$108.1m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
The company Calcimedica has raised a total of $26m in funding over 12 rounds.